Press ReleasesArchived Press ReleasesFor information regarding press releases please contact us at:
Phone: (402) 452-5437
Fax: (402) 452-5461
E-mail: investorrelations@transgenomic.com DisclaimerThe following historical press releases contain statements that reflected management's views and estimates of future economic circumstances, industry conditions, company performance and financial results applicable on the dates they were first issued. Investors should not assume that statements made in these documents remain accurate and complete as of any later date. Such statements were and remain subject to certain factors, risks and uncertainties, including those described in Transgenomic, Inc.'s reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties could have caused the actual results, events and performance to differ materially from those referred to in such statements. Transgenomic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any of these documents to reflect any change in Transgenomic's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements were based. Available Archives2005 Archive| December 8, 2005 | View | ASH Sessions Highlight Contributions of Transgenomic Technology to Leukemia Research | | | | November 8, 2005 | View | Transgenomic Inc. Reports Third Quarter 2005 Results | | | | November 8, 2005 | View | Reminder - Webcast Alert: Transgenomic Inc. Announces Third Quarter 2005 Earnings Release Conference Call Webcast | | | | November 7, 2005 | View | Webcast Alert: Transgenomic Inc. Announces Third Quarter 2005 Earnings Release Conference Call Webcast | | | | October 31, 2005 | View | Transgenomic Closes on Previously Announced Private Placement of Common Stock | | | | October 17, 2005 | View | Transgenomic’s WAVE® System and Surveyor™ Nuclease Used for Detection and Monitoring of Low-Level Mutation in Mast Cell Leukemia | | | | September 23, 2005 | View | Transgenomic Announces over $15 Million Private Placement of Common Stock | | | | September 19, 2005 | View | Transgenomic Regains Compliance with NASDAQ Continued Listing Standard | | | | August 11, 2005 | View | Transgenomic Inc. Reports Second Quarter 2005 Results | | | | August 11, 2005 | View | Reminder - Webcast Alert: Transgenomic Inc. Announces Second Quarter 2005 Earnings Release Conference Call Webcast | | | | August 10, 2005 | View | Transgenomic’s WAVE® System Used to Address Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors | | | | August 9, 2005 | View | Webcast Alert: Transgenomic Inc. Announces Second Quarter 2005 Earnings Release Conference Call Webcast | | | | July 13, 2005 | View | Transgenomic Projects Neutral to Positive Operating Cash Flow by Year-End | | | | June 20, 2005 | View | Transgenomic’s WAVE® System Used for Early Detection of Drug Resistance Mutations in Chronic Myeloid Leukemia | | | | May 17, 2005 | View | Transgenomic Inc. Reports First Quarter 2005 Results | | | | May 16, 2005 | View | Webcast Alert: Transgenomic Inc. Announces First Quarter 2005 Earnings Release Conference Call Webcast | | | | April 20, 2005 | View | Transgenomic, Inc. Continues to Provide Specialty Nucleic Acid Products to Geron Corporation | | | | April 18, 2005 | View | AACR Sessions Highlight Contributions of Transgenomic Technology to Cancer Research | | | | March 31, 2005 | View | Transgenomic Inc. Reports Fourth Quarter and Fiscal Year 2004 Results | | | | March 18, 2005 | View | Transgenomic Secures Additional Financing | | | | February 24, 2005 | View | Transgenomic Completes Expense Reduction Plan on Target | | | | February 22, 2005 | View | Transgenomic Inc. Announces Launch of Wave® Microbial Analysis System | | |
|